General Information of Drug (ID: DMCJI5P)

Drug Name
N-1177-inh
Synonyms
N-1177; PH-50; WIN-67722; Imaging agent (cancer), IMCOR; Imaging agent (cancer), Photogen; Imaging agent (cardiovascular), IMCOR; Imaging agent (cardiovascular), Photogen; N-1177-iv; N-1177-sq; N-1177-sq); Nanoparticle contrast agent (atherosclerosis), NanoScan Imaging; Nanoparticle contrast agent (cancer), NanoScan Imaging; Nanoparticle contrast agent (pulmonary tumor), NanoScan Imaging; N-1177 (inhaled, lung cancer), NanoScan Imaging; N-1177 (intravenous,atherosclerosis), NanoScan Imaging; N-1177 (subcutaneous,cancer), NanoScan Imaging
Indication
Disease Entry ICD 11 Status REF
Lymphoma 2A80-2A86 Discontinued in Phase 1 [1]
Structure 3D Structure is Not Available
3D MOL 2D MOL
Cross-matching ID
TTD ID
D0I4FL

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015744)